| 2024-11-18 | +0.76 % |
|
| 2024-11-15 | -1.89 % |
|
| 2024-11-11 | -0.13 % |
|
| 2024-11-08 | +2.32 % |
|
| 2024-10-31 | -1.93 % |
|
| 2024-10-30 | -0.49 % |
- Jim Cramer discussed various stocks including Intuitive Surgical (ISRG), which experienced a decline of 0.49%, although the article does not specify the reasons for this drop.
- Intuitive Surgical (ISRG) stock declined by 0.49% due to potential concerns over slowing growth in the surgical market and market volatility, similar to observed trends in the streaming industry, notably with Netflix's recent challenges in subscriber growth and revenue projections.
- Intuitive Surgical (ISRG) stock declined by 0.49% partly due to the recent sale of 22 shares by Senior Vice President Mark Brosius, which may have raised concerns about insider selling among investors, alongside mixed analyst ratings and varying price target adjustments.
- Intuitive Surgical (ISRG) stock dipped by 0.49% despite significant investment interest, including a notable 288.7% increase in stakes by Creekmur Asset Management, likely indicating broader market influences or profit-taking among investors.
- Intuitive Surgical (ISRG) stock experienced a decrease of 0.49% following the sale of 1,012 shares by EVP Robert Desantis, which could indicate insider selling that often raises concerns among investors.
- Intuitive Surgical (ISRG) stock experienced a decline of 0.49% following the sale of 188 shares by EVP Robert Desantis, which may have raised concerns among investors regarding insider selling.
|
| 2024-10-29 | +1.06 % |
|
| 2024-10-28 | -0.08 % |
- The article discusses the upcoming Q3 earnings report for Eli Lilly, highlighting expected sales growth driven by its diabetes and obesity drugs, but it does not directly address Intuitive Surgical (ISRG) stock. The reason for the slight decline in ISRG stock (-0.08%) is not mentioned in the article.
- Intuitive Surgical (ISRG) stock decreased by 0.08% after SVP Mark Brosius sold 22 shares, likely contributing to negative market sentiment.
- Intuitive Surgical, Inc. (ISRG) stock dipped by 0.08% as FCG Investment Co disclosed acquiring a new stake in the company, purchasing 2,150 shares valued at about $1,056,000, which may have contributed to market fluctuations affecting the stock. The decline could be attributed to broader market dynamics or investor sentiment rather than the specific acquisition.
- The article discusses the recent fluctuations in Monopar Therapeutics' stock price due to a significant licensing agreement, while briefly mentioning that Intuitive Surgical's stock saw a minor decline of 0.08%. The stock of Intuitive Surgical (ISRG) likely went down due to broader market trends or investor focus shifting towards the more dramatic gains of other stocks like Monopar rather than specific negative news about ISRG.
- Intuitive Surgical (ISRG) stock experienced a slight decline of 0.08% amid mixed institutional investment activity, with NorthCrest Asset Management increasing its stake, while various hedge funds adjusted their positions, reflecting broader investor sentiment and market dynamics. The decrease in stock value may be attributed to profit-taking by insiders and the potential volatility seen in tech-related medical stocks over recent trading sessions.
|
| 2024-10-25 | -0.07 % |
|
| 2024-10-24 | -0.19 % |
|
| 2024-10-23 | -0.95 % |
|
| 2024-10-22 | -0.26 % |
- Intuitive Surgical (ISRG) stock experienced a slight decline of 0.26% due to broader market volatility and potential investor caution ahead of the upcoming US elections, which may influence market sentiment and investment decisions.
- Intuitive Surgical (ISRG) stock fell by 0.26% amidst mixed market sentiment, despite Commonwealth Equity Services LLC increasing its stake by 3.6% in the third quarter. The decline may be attributed to broader market trends or investor reactions rather than specific negative news about the company itself.
- Intuitive Surgical (ISRG) stock fell by 0.26%, possibly due to profit-taking by insiders as well as a general market reaction to various recent price target adjustments and sales of shares by executives.
- Intuitive Surgical (ISRG) stock declined by 0.26% following insider share sales and an overall cautious sentiment in the market despite significant institutional investments and positive price target adjustments from several brokerages.
The stock decrease may be attributed to the selling by insiders, which can signal potential lack of confidence, alongside market adjustments and mixed analyst ratings, possibly leading investors to reassess their positions.
- Intuitive Surgical (ISRG) stock declined by 0.26%, attributed to recent insider selling and mixed analyst ratings, despite significant institutional investment growth in the company.
- Intuitive Surgical (ISRG) saw a slight decline of 0.26% in its stock price following a period of significant growth, despite its remarkable 800% increase over the past decade, likely due to profit-taking or market fluctuations after a strong earnings report.
- Intuitive Surgical (ISRG) stock dipped by 0.26% despite several analysts raising their price targets and maintaining positive ratings for the company, likely due to profit-taking from investors following recent price increases and insider selling activity.
|
| 2024-10-18 | +10.01 % |
- Intuitive Surgical (ISRG) shares rose by 10.01% following strong third-quarter earnings and revenue results that exceeded analyst expectations, signaling robust financial performance and growth potential.
- Intuitive Surgical (ISRG) stock rose 10.01% following Royal Bank of Canada's upgrade of its target price from $525 to $555 and its "outperform" rating, indicating increased investor confidence in the company's performance.
- Intuitive Surgical's stock surged by 10.01% following a strong profit report that exceeded analysts' expectations and demonstrated better-than-anticipated revenue, indicating strong performance and investor confidence in the company's growth.
- Intuitive Surgical (ISRG) stock rose by 10.01% following the company's strong earnings report, which exceeded profit and sales expectations driven by high demand for its da Vinci minimally invasive surgical devices.
- Intuitive Surgical (ISRG) stock rose by 10.01% following a report that Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in the company by 5.3% in the third quarter, indicating institutional confidence in the stock.
- Intuitive Surgical (ISRG) stock rose by 10.01% due to strong third-quarter earnings, contributing to a broader rally in US stocks, with the Dow and S&P 500 reaching all-time highs.
- Intuitive Surgical's stock (NASDAQ:ISRG) surged over 10% following a strong third-quarter 2024 earnings report, highlighted by a 17% increase in revenue and a significant rise in da Vinci procedure volume, reflecting the company's growing strength in the market for robotic-assisted surgery. The stock rose due to strong financial performance, increased sales of systems and accessories, and new regulatory approvals that open additional markets.
- Intuitive Surgical (ISRG) stock rose by 10.01% due to the company reporting third-quarter earnings that exceeded Wall Street estimates for both revenues and profits, contributing to the overall positive sentiment in the market as investors reacted to strong earnings reports from several major companies.
- Intuitive Surgical's (ISRG) stock surged 10.01% following the release of its third-quarter earnings report, which exceeded analysts' profit and revenue expectations, contributing to a broader rally in the US stock market as major indices reached record highs.
|
| 2024-10-17 | -0.6 % |
|
| 2024-10-16 | -0.39 % |
|
| 2024-10-15 | -1.87 % |
|
| 2024-10-14 | +0.58 % |
|
| 2024-10-11 | +0.19 % |
|
| 2024-10-09 | +1.99 % |
- Intuitive Surgical, Inc. (ISRG) saw a 1.99% increase in stock price due to positive growth indicators such as a 17% rise in procedures using its robotic systems, financial strength with no debt and over $3 billion in cash, and an overall favorable market environment following interest rate cuts and resilient economic growth.
- Intuitive Surgical, Inc. (ISRG) saw a 1.99% increase in its stock price, driven by institutional investors, such as True North Advisors and Creekmur Asset Management, increasing their stakes, positive target price adjustments by analysts, and strong quarterly earnings results exceeding expectations.
- Intuitive Surgical, Inc. (ISRG) stock rose by 1.99% after Dynamic Advisor Solutions LLC increased its investment in the company by 3.1% as part of a trend where multiple institutional investors are buying and holding shares, reflecting confidence in the company’s growth potential following strong earnings results and positive analyst upgrades.
|
| 2024-10-08 | +2.03 % |
|
| 2024-10-04 | +0.48 % |
|
| 2024-10-03 | -1.44 % |
|
| 2024-10-01 | -1.33 % |
|
| 2024-09-27 | -1.47 % |
|
| 2024-09-26 | +0.4 % |
|
| 2024-09-24 | -0.95 % |
|
| 2024-09-20 | -0.78 % |
|
| 2024-09-10 | +1.01 % |
|
| 2024-09-09 | +1.6 % |
|
| 2024-09-06 | -1.02 % |
|
| 2024-09-04 | -0.35 % |
|
| 2024-08-09 | -0.04 % |
|
| 2024-08-07 | +0.36 % |
|
| 2024-08-02 | -0.27 % |
|
| 2024-07-23 | -1.31 % |
|
| 2024-07-22 | +1.34 % |
|
| 2024-07-19 | +9.34 % |
- Intuitive Surgical(ISRG) stock was up 9.34% last night as the company beat profit and sales forecasts due to the increased use of their da Vinci surgical machine.
- Intuitive Surgical Inc. (NASDAQ: ISRG) stock went up by 9.34% after reporting better-than-expected second-quarter earnings, with analysts attributing the stock's rise to strong momentum supported by growth in general surgery and non-urology procedures, ongoing technological advancements, positive financial outlook, expanding robotic-assisted surgery potential, and new product launches, leading to increased price targets and favorable ratings from various analysts.
- Intuitive Surgical (ISRG) stock went up by 9.34% on Friday following the company's second-quarter 2024 financial results, which exceeded revenue and earnings per share (EPS) expectations due to robust demand for its Da Vinci 5 (Dv5) system and improved margins, leading analysts to raise price targets based on strong procedure growth and potential impacts of new product cycles including labeling revision approval by the U.S. Food and Drug Administration (FDA) for da Vinci X and Xi surgical systems.
- The stock of Intuitive Surgical Inc. (NASDAQ: ISRG) rose by 9.34% after the company reported better-than-expected second-quarter earnings, despite facing challenges such as China macroeconomic issues and anti-corruption efforts. The stock went up as investors reacted positively to the company's positive financial performance.
- Intuitive Surgical (ISRG) stock surged by 9.34% following Truist Securities' positive outlook, based on the company surpassing revenue and earnings expectations in the second quarter due to increased procedures and system sales, particularly the newer da Vinci 5 (D5) systems, demonstrating strong growth potential and market leadership in robotic surgery, leading to various analyst firms raising their price targets on the stock.
|
| 2024-07-18 | -2.37 % |
- The article discusses how Barclays analyst Matt Miksic increased the price target for Intuitive Surgical (ISRG) stock, anticipating a potential upside of 17.5%, but despite this positive outlook, the stock experienced a -2.37% dip, possibly influenced by broader market conditions, sector trends, or specific company developments.
- The article discusses the recent market volatility, with a focus on the semiconductor industry, including TSMC's strong earnings report and a decline in U.S. chip stocks due to fears of tighter export restrictions. Intuitive Surgical (ISRG) stock had declined -2.37% the night before, likely impacted by the negative sentiment in the tech sector as well as broader market uncertainty surrounding chipmakers.
- The article discusses the Capital Group Growth ETF (CGGR), an actively managed growth ETF that has outperformed the market since its inception in early 2022, with its diversified portfolio and experienced portfolio managers. The article does not mention why Intuitive Surgical (ISRG) stock went down by -2.37%.
- Summary: Intuitive Surgical (ISRG) reported strong second-quarter results, beating analyst expectations with adjusted EPS and revenue, which led to a 6.6% increase in stock value initially; however, last night the stock was down by -2.37%, possibly due to general market fluctuations, profit-taking, or investor sentiment shifts.
Reason for Stock Decline: The decline in Intuitive Surgical's stock price could be attributed to various factors such as broader market conditions, profit-taking by investors following the initial positive response to the earnings beat, geopolitical events impacting market sentiment, or short-term fluctuations driven by traders.
|
| 2024-07-17 | -2.69 % |
|
| 2024-07-05 | +2.06 % |
- The article discusses that Intuitive Surgical Inc (NASDAQ:ISRG) stock went up by 2.06% and highlights Jim Cramer's positive view on the company, emphasizing its bullish outlook due to factors such as its impressive performance, strong quarterly results, technological advancements, and future growth potential in the robotic surgery market. Cramer and Wall Street believe the company is well positioned for long-term growth, with increased procedure volume and revenue growth, making it a top stock recommendation.
- The article compares Monster Beverage stock to Intuitive Surgical stock, stating that although Intuitive Surgical has better revenue growth, Monster Beverage is more profitable and likely to outperform. Intuitive Surgical's revenue growth has been driven by increased procedure volume and a growing installed base, while Monster Beverage's revenue growth is due to demand for its energy drinks and new product expansion. Callable features that support why Monster Beverage stock may be a better choice included its recent pricing actions and focus on cost-cutting efforts, alongside a growing demand for energy drinks. This analysis suggests that while Intuitive Surgical stock has seen a rally in recent times, Monster Beverage's stock potentially offers greater future returns.
|
| 2024-06-28 | -0.06 % |
|
| 2024-06-25 | +3.09 % |
|
| 2024-06-21 | |
- Summary: The article discusses the rising popularity of halal investing, particularly in debt-free Halal stocks, such as Intuitive Surgical(ISRG), and highlights the growth of the global halal market. It also mentions the Amana Growth Fund and the Azzad Ethical fund as Islamic investment options. The article provides information about Acumen Pharmaceuticals, Inc., a promising debt-free, halal stock, that analysts recommend as a buy due to its strong potential in developing disease-modifying treatments for Alzheimer's disease.
Reason for ISRG stock going down: The specific reason for Intuitive Surgical(ISRG) stock going down by 0.0% last night is not mentioned in the article. Stock prices fluctuate due to various factors such as market conditions, investor sentiment, company performance, and external events, which can all contribute to the movement of stock prices.
- The article discusses the concept of halal investing, highlighting Absci Corporation as one of the best debt-free halal stocks to consider, supported by its AI-powered drug discovery platform, while also mentioning top holdings and financial data for Absci Corporation. Intuitive Surgical(ISRG) stock was 0.0% down and this could be due to various market factors such as general market conditions, company-specific news, or investor sentiment.
- The article highlights the growing popularity of Halal investing, focusing on debt-free Halal stocks and mentioning Intuitive Surgical (ISRG) as one of the best stocks to consider, among others, driven by the increasing demand for halal products and services. The specific reason for ISRG stock going down last night is not mentioned in the article.
- The article discusses halal investing and highlights Intuitive Surgical (ISRG) among other debt-free Halal stocks as potential investment options, attributed to the growing demand for halal products and services driven by Muslim millennials. The stock of Intuitive Surgical may have gone down due to various factors such as market conditions, company performance, or investor sentiment.
- Summary: The article discusses the rise in popularity of Halal investing, focusing on debt-free Halal stocks that operate in accordance with Islamic principles. It mentions Intuitive Surgical (ISRG) as one of the companies considered a good debt-free Halal stock to invest in.
Intuitive Surgical's stock likely went down due to general market conditions, company-specific developments, or changes in investor sentiment.
|
| 2024-06-14 | +0.68 % |
|
| 2024-06-13 | -1.21 % |
|
| 2024-06-11 | +0.1 % |
|
| 2024-06-07 | -0.13 % |
|
| 2024-06-05 | +2.61 % |
|
| 2024-06-04 | +0.68 % |
|
| 2024-05-30 | +1.25 % |
- The article summarizes the latest research calls on Wall Street, highlighting upgrades to stocks such as PayPal, Datadog, Okta, C3.ai, and U.S. Cellular, as well as downgrades to stocks like UiPath, Cava Group, First Solar, Generac, and FactSet. Intuitive Surgical (ISRG) stock was initiated with a Buy rating and $500 price target by Goldman Sachs, attributing potential growth to increased penetration of robotic-assisted surgery enabled by next-generation product advances. The stock likely went up last night due to this positive initiation and long-term growth prospects as indicated by the research call.
- Goldman Sachs initiated coverage on Intuitive Surgical (ISRG) with a Buy rating, citing factors such as potential growth through increased penetration of robotic-assisted surgery, development of next-generation products, and a fully-integrated care delivery model. The optimism surrounding ISRG stock is also based on projected positive momentum in profit and loss starting in 2026, with a 20% growth in earnings per share expected through 2028. The company's strong market position, focus on innovation in robotic-assisted surgery, and financial stability contribute to the positive outlook, reflected in the $500.00 price target. The stock went up 1.25% on the day due to Goldman Sachs’ positive coverage and the company's solid financial performance, with metrics such as a high P/E ratio and significant stock price increase over the last six months.
|
| 2024-05-29 | -0.66 % |
|
| 2024-05-24 | +1.62 % |
|
| 2024-05-23 | -0.63 % |
|
| 2024-05-22 | -0.3 % |
|
